Akari Therapeutics Plc SEC filings AKTX
Akari Therapeutics Plc has 743 filings in SEC EDGAR's recent list, going back to Apr 13, 2012. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Jun 6, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Apr 15, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Jun 4, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 29, 2024 | Dec 31, 2023 |
| 20-F | Annual report (foreign issuer) | May 1, 2023 | Dec 31, 2022 |
| 20-F | Annual report (foreign issuer) | May 16, 2022 | Dec 31, 2021 |
| 20-F | Annual report (foreign issuer) | Apr 21, 2021 | Dec 31, 2020 |
| 20-F | Annual report (foreign issuer) | Mar 31, 2020 | Dec 31, 2019 |
| 20-F | Annual report (foreign issuer) | Apr 23, 2019 | Dec 31, 2018 |
| 20-F | Annual report (foreign issuer) | Jul 18, 2018 | Dec 31, 2017 |
| 20-F | Annual report (foreign issuer) | Mar 31, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Mar 23, 2016 | Dec 31, 2015 |
| ARS | Annual report to shareholders | Jun 10, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Feb 11, 2015 | Dec 31, 2014 |
| 20-F/A | Amended annual report (foreign issuer) | Apr 7, 2014 | Dec 31, 2013 |
| 20-F | Annual report (foreign issuer) | Mar 24, 2014 | Dec 31, 2013 |
| 20-F/A | Amended annual report (foreign issuer) | Apr 19, 2013 | Dec 31, 2012 |
| 20-F | Annual report (foreign issuer) | Mar 22, 2013 | Dec 31, 2012 |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AKTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- United Kingdom
- Headquarters
- Tampa, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1541157
- Former names
- Celsus Therapeutics Plc. (until Sep 15, 2015); Morria Biopharmaceuticals PLC (until Jun 20, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.